Craig Fleming, MD; Evelyn P. Whitlock, MD, MPH; Tracy L. Beil, MS; Frank A. Lederle, MD
Fleming C, Whitlock EP, Beil TL, Lederle FA. Screening for Abdominal Aortic Aneurysm: A Best-Evidence Systematic Review for the U.S. Preventive Services Task Force. Ann Intern Med. 2005;142:203-211. doi: 10.7326/0003-4819-142-3-200502010-00012
Download citation file:
Published: Ann Intern Med. 2005;142(3):203-211.
While the prognosis for abdominal aortic aneurysm (AAA) rupture is poor, ultrasound imaging is an accurate and reliable test for detecting AAAs before rupture.
To examine the benefits and harms of population-based AAA screening.
MEDLINE (1994 to July 2004) supplemented by the Cochrane Library, a reference list of retrieved articles, and expert suggestions.
Randomized trials of AAA population screening, population studies of AAA risk factors, and data on adverse screening and treatment events from randomized trials and cohort studies.
All studies were reviewed, abstracted, and rated for quality by using predefined criteria.
The authors identified 4 population-based randomized, controlled trials of AAA screening in men 65 years of age and older. On the basis of meta-analysis, an invitation to attend screening was associated with a significant reduction in AAA-related mortality (odds ratio, 0.57 [95% CI, 0.45 to 0.74]). A meta-analysis of 3 trials revealed no significant difference in all-cause mortality (odds ratio, 0.98 [CI, 0.95 to 1.02]). No significant reduction in AAA-related mortality was found in 1 study of AAA screening in women. Screening does not appear to be associated with significant physical or psychological harms. Major treatment harms include an operative mortality rate of 2% to 6% and significant risk for major complications.
The population screening studies focused on men and provided no information on racial or ethnic groups. No information was available on uninvited control group characteristics, so the importance of risk factors such as tobacco use or family history could not be assessed. Since all trials were conducted in countries other than the United States, generalizability to the U.S. population is uncertain.
For men age 65 to 75 years, an invitation to attend AAA screening reduces AAA-related mortality.
MASS = Multicentre Aneurysm Screening Study; OR = odds ratio.
MASS = Multicentre Aneurysm Screening Study; OR = odds ratio. *Age = standardized numbers were used for the Western Australia trial because of an early age imbalance that was subsequently corrected (24).
KQ = key question. KQ 1a = Does AAA screening, in an asymptomatic average-risk or high-risk population, reduce AAA-related adverse health outcomes? KQ 1b = For individuals who do not have AAAs on initial screening, does periodic repeated screening reduce AAA-related adverse health outcomes? KQ 2 = What are the harms associated with AAA screening? KQ 3 = For AAAs 3.0 to 5.4 cm detected through screening, does immediate repair or surveillance reduce AAA-related adverse health outcomes? KQ 4 = What are the harms associated with repair of AAAs 5.5 cm or greater? KQ 5 = What are the harms associated with immediate repair or surveillance of AAAs 3.0 to 5.4 cm?
All abstracts were reviewed for relevance to other KQs. Articles from experts or reference lists were also reviewed if relevant.
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only